BACKGROUND: Previously, nonselective beta-blockade (BB) with propranolol demonstrated protection of the bone marrow (BM) after trauma and hemorrhagic shock (HS). Because selective beta-1 blockers are used commonly for their cardiac protection, the aim of this study was to more clearly define the role of specific beta adrenergic receptors in BM protection after trauma and HS. METHODS: Male Sprague-Dawley rats underwent unilateral lung contusion (LC) followed by HS for 45 minutes. After resuscitation, animals were injected with a selective beta-blocker, atenolol (B1B), butoxamine (B2B), or SR59230A (B3B). Animals were killed at 3 hours or 7 days. Heart rate and blood pressure were measured throughout the study period. BM cellularity, growth of hematopoietic progenitor cells (HPCs) in BM, and hemoglobin levels (Hb) were assessed. RESULTS: Treatment with a B2B or B3B after LCHS restored both BM cellularity and BM HPC colony growth at 3 hours and 7 days. In contrast, treatment with a B1B had no effect on BM cellularity or HPC growth but did decrease heart effectively rate throughout the study. Treatment with a B3B after LCHS increased Hb as compared with LCHS alone. CONCLUSION: After trauma and HS, protection of BM for 7 days was seen with use of either a selective beta-2 or beta-3 blocker. Use of a selective beta-1 blocker was ineffective in protecting the BM despite a physiologic decrease in heart rate. Therefore, the protection of BM is via the beta-2 and beta-3 receptors and it is not via a direct cardiovascular effect. Published by Mosby, Inc.
BACKGROUND: Previously, nonselective beta-blockade (BB) with propranolol demonstrated protection of the bone marrow (BM) after trauma and hemorrhagic shock (HS). Because selective beta-1 blockers are used commonly for their cardiac protection, the aim of this study was to more clearly define the role of specific beta adrenergic receptors in BM protection after trauma and HS. METHODS: Male Sprague-Dawley rats underwent unilateral lung contusion (LC) followed by HS for 45 minutes. After resuscitation, animals were injected with a selective beta-blocker, atenolol (B1B), butoxamine (B2B), or SR59230A (B3B). Animals were killed at 3 hours or 7 days. Heart rate and blood pressure were measured throughout the study period. BM cellularity, growth of hematopoietic progenitor cells (HPCs) in BM, and hemoglobin levels (Hb) were assessed. RESULTS: Treatment with a B2B or B3B after LCHS restored both BM cellularity and BM HPC colony growth at 3 hours and 7 days. In contrast, treatment with a B1B had no effect on BM cellularity or HPC growth but did decrease heart effectively rate throughout the study. Treatment with a B3B after LCHS increased Hb as compared with LCHS alone. CONCLUSION: After trauma and HS, protection of BM for 7 days was seen with use of either a selective beta-2 or beta-3 blocker. Use of a selective beta-1 blocker was ineffective in protecting the BM despite a physiologic decrease in heart rate. Therefore, the protection of BM is via the beta-2 and beta-3 receptors and it is not via a direct cardiovascular effect. Published by Mosby, Inc.
Authors: Michael Krzyzaniak; Carrie Peterson; William Loomis; Ann-Marie Hageny; Paul Wolf; Luiz Reys; James Putnam; Brian Eliceiri; Andrew Baird; Vishal Bansal; Raul Coimbra Journal: J Trauma Date: 2011-05
Authors: Alicia M Mohr; Ihab O ElHassan; Edward J Hannoush; Ziad C Sifri; Michael D Offin; Walter D Alzate; Pranela Rameshwar; David H Livingston Journal: J Trauma Date: 2011-05
Authors: Angela Penn; Alicia M Mohr; Salil G Shah; Ziad C Sifri; Vicki L Kaiser; Pranela Rameshwar; David H Livingston Journal: J Surg Res Date: 2010-04-18 Impact factor: 2.192
Authors: Keith A Beiermeister; Brett M Keck; Ziad C Sifri; Ihab O ElHassan; Edward J Hannoush; Walter D Alzate; Pranela Rameshwar; David H Livingston; Alicia M Mohr Journal: J Trauma Date: 2010-08
Authors: Chirag D Badami; David H Livingston; Ziad C Sifri; Francis J Caputo; Larissa Bonilla; Alicia M Mohr; Edwin A Deitch Journal: J Trauma Date: 2007-09
Authors: Shirin Hasan; Michael J Mosier; Andrea Szilagyi; Richard L Gamelli; Kuzhali Muthumalaiappan Journal: Surgery Date: 2017-07-14 Impact factor: 3.982
Authors: Amy V Gore; Letitia E Bible; Kimberly Song; David H Livingston; Alicia M Mohr; Ziad C Sifri Journal: J Trauma Acute Care Surg Date: 2015-07 Impact factor: 3.313
Authors: Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2015-07 Impact factor: 3.313
Authors: Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr Journal: Surgery Date: 2015-07-21 Impact factor: 3.982
Authors: Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Walter D Alzate; David H Livingston; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2014-04 Impact factor: 3.313